
Developer of Cardiac Ultrasound Simulator

Digital Solution Provider

Medical Device Media Reporting Pioneer
Share Professional Medical Device Knowledge
Source:Instrument Family,Reproduction without authorization is prohibited, and reproduction is allowed 24 hours later.
On July 18 local time, GE Healthcare announced that it had reached an agreement,GE Healthcare to Acquire Intelligent Ultrasound Group's Clinical AI Software Business for $51 Million (Approx. RMB 370 Million)

IUG Focuses on Developing Integrated AI-Driven Image Analysis Tools, Committed to Enhancing the Intelligence and Efficiency of Ultrasound Technology.GE Healthcare plans to fully integrate these advanced AI solutions into its ultrasound product line, thereby optimizing workflows and enhancing the user experience for clinicians and patients.
According to the agreement, the product software and R&D team of IUG Clinical AI will be integrated into GE Healthcare, serving as a strong complement to the existing AI equipment portfolio., and accelerate the development of its next-generation AI tools.Currently, GE Healthcare ranks first among medical technology companies in terms of the number of AI device authorizations granted by the FDA.
Data shows that Intelligent Ultrasound Group plc (IUG), a leading AI software and simulator company for ultrasound based in the UK, is committed to enhancing the ultrasound imaging and diagnostic capabilities in the healthcare industry through innovative artificial intelligence and simulation technologies.
The company currently has two majorMain Business:Clinical AI Business and Ultrasound Simulator Business.Among them, clinical AI includes ScanNav Anatomy PNB (for real-time AI-assisted regional anesthesia and analgesia) and ScanNav Assist (real-time AI image analysis for obstetric ultrasound).
ScanNav Anatomy PNB
ScanNav Anatomy Peripheral Nerve Block (PNB)Aimed at improving the accuracy and standardization of ultrasound image interpretation by providing color overlays of key anatomical structures during real-time ultrasound scanning.

This solution was co-developed by IUG and leading experts in the field of anesthesiology.Supports highlighting anatomical structures in 10 key areas.These areas are related to regional anesthesia and analgesia under ultrasound guidance, including all seven "Plan A" block methods.
ScanNav Assist
ScanNav Assist is the core of GE Healthcare's SonoLyst software.As early as 2019, IUG signed an exclusive agreement with GE Healthcare to integrate this real-time AI image analysis technology for obstetric ultrasound into GE Healthcare's Voluson Expert, Voluson Signature, and Voluson Swift ultrasound devices.
According to reports,GE Healthcare's SonoLyst is the world's first fully integrated AI tool capable of identifying 20 fetal ultrasound image views recommended by the International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) Mid-Trimester Practice Guidelines.

According to statistics, as examinations become increasingly complex, 81% of hospitals face a shortage of radiologic technologists, and 90% of ultrasound technicians experience heavy workloads and repetitive tasks.Musculoskeletal disorders caused by movements or other reasons.
GE Healthcare's acquisition this time aims to reduce manual operations and enable clinicians to focus more on patient care by streamlining workflows and introducing AI-driven protocols.Moreover, the deal will further enhance GE Healthcare's AI device lineup and accelerate the development of its next-generation AI tools.Currently, GE Healthcare ranks first among medical technology companies in terms of the number of AI device authorizations granted by the FDA.

This is also GE Healthcare's first move after completing its spin-off and becoming independent, followingThe second AI-related deal after acquiring Caption Health.
In January 2023, GE Healthcare was officially spun off from GE Group and listed on the NASDAQ Stock Exchange in the United States.After becoming independent, GE Healthcare has continuously strengthened its layout in the artificial intelligence field through mergers, acquisitions, and collaborations.
In September last year, GE Healthcare revealed plans to develop an artificial intelligence (AI)-assisted ultrasound imaging automatic assessment tool in the future,Used to increase access to high-quality medical services around the world.
In February last year, the company also acquired Caption Health, a developer of AI ultrasound technology.Adding AI-driven ultrasound technology to its product portfolio, further strengthening its layout in medical imaging AI. Currently, Caption Health has launched an FDA-approved artificial intelligence-assisted cardiac ultrasound diagnostic software.
In January this year, GE Healthcare announced plans to acquire MIM Software, a provider of artificial intelligence and medical imaging analysis.Integrate its innovative solutions into its advanced visualization products, further expanding its capabilities in medical imaging analysis and digital solutions to provide patients with smarter, more personalized, and differentiated healthcare solutions.

Focus on Artificial Intelligence
GE Healthcare CEO Peter Arduini said in an interview that many of the company's current R&D priorities are still more focused on artificial intelligence. He pointed outAI plays an important role in medical imaging equipment such as MRI, CT, and ultrasound, and customers are willing to pay higher prices for these advanced products.And added that GE Healthcare's R&D investment over the past year has already led to the creation of 40 new products, which will have a "flywheel effect" on the business.
In addition, Arduini stated: "The last part we are building and will develop in the next few years is so-called multimodal data integration.——Your genomic information, pathological information, and imaging data. All this data is aggregated in one pane, and there is a specific algorithm or foundational model that can help interpret the data, assisting clinicians in guiding patients in the right direction."
GE Healthcare Imaging is currently the largest of the company's four major businesses, with revenue of approximately $10.6 billion in the 2023 fiscal year. The company has developed many software tools for medical imaging management and analysis, including Picture Archiving and Communication Systems (PACS), Radiology Information Systems (RIS), and various other tools.Products cover CT, MR, molecular imaging, X-ray, women's health, image-guided therapy, enterprise imaging software, services, and digital solutions.etc.

Among them,Imaging business achieved revenue of $10.581 billion, accounting for 54% of the company's total revenue; Ultrasound business achieved revenue of $3.457 billion, accounting for 17.7% of the company's total revenue.
As an ultrasound leaderThe absolute leader in the field,GE Healthcare has established a presence in high-end, mid-range, and low-end markets, and is a leader in application markets such as obstetrics, radiology, and cardiology.Currently, GE Healthcare's ultrasound product portfolio has expanded from the diagnostic field to the surgical visualization field, laying a solid foundation for its latest target, the AI ultrasound track.
The 5th Generation Ultrasound Product: Fortis Series
In early August 2021, GE Healthcare officially launched the Fortis series, the fifth-generation ultrasound product family. The new generation of ultrasound technology has undergone a transformation from hardware beamforming to software beamforming, and from circuit boards + code to GPU + software,告别了四十余年硬件波束形成器平台,实现了技术上的本质性突破.
Fortis Series Ultrasound Products
It is reported that based on the cSound™ soft beam imaging platform, the Fortis series has successfully broken through the technical ceiling of ultrasound engineering, bringing outstanding features such as full-field pixel focusing, high frame rate, high real information content, and AI artificial intelligence to imaging diagnostics.
High-End Obstetrics and Gynecology Ultrasound Voluson

New Generation CyberKnife
In April this year, GE Healthcare announced the launch of Caption AI, an artificial intelligence (AI)-driven software, for its dual-headed, handheld, wireless, point-of-care ultrasound imaging system, Vscan Air SL.

This imaging system officially launched in August 2023, allowing clinicians to efficiently capture and view clear images of the heart and blood vessels at the patient’s bedside, thereby accelerating diagnostic and treatment decisions. With the addition of Caption AI,Clinicians using the Vscan Air SL handheld ultrasound will be able to obtain real-time, step-by-step guidance to capture diagnostic-quality images and automatic ejection fraction estimates, thereby assisting in clinical decision-making in cardiac settings.
--
According to GrandView Research, the global ultrasound device market size was $7.9 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 4.5% from 2022 to 2030.GE Healthcare, as the absolute leader in this field, has consistently ranked first globally in revenue, with a market share of 29%.
WorthIt is worth noting that the competitive landscape of the ultrasound market is basically mature, with little change in recent years. The acquisition of IUG's clinical AI software business will not only further consolidate its market position but also achieve "self-transcendence." In this regard, Device China will continue to follow up.
More exciting content
Welcome to follow WeChat Video Channel


Join【Device Home】WeChat Communication GroupPlease add uniformlyAdministrator WeChat
Please uniformly note: Company + Name/Nickname (Otherwise, it will not be approved)


BusinessBusiness cooperation email: qxzj@landianyiliao.com

